Pacer Advisors’s Corcept Therapeutics CORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$128K Buy
3,184
+1,154
+57% +$43.2K ﹤0.01% 1808
2025
Q4
$70.6K Sell
2,030
-388,529
-99% -$30.5M ﹤0.01% 3207
2025
Q3
$32.5M Buy
390,559
+384,896
+6,797% +$27.9M 0.08% 232
2025
Q2
$416K Sell
5,663
-5,237
-48% -$380K ﹤0.01% 1473
2025
Q1
$1.24M Buy
10,900
+4
+0% +$243 ﹤0.01% 1119
2024
Q4
$549K Buy
10,896
+1,689
+18% +$88.5K ﹤0.01% 1586
2024
Q3
$426K Buy
9,207
+5,355
+139% +$190K ﹤0.01% 1687
2024
Q2
$125K Buy
3,852
+2,728
+243% +$74.7K ﹤0.01% 2134
2024
Q1
$28.3K Sell
1,124
-173
-13% -$4.09K ﹤0.01% 3371
2023
Q4
$42.1K Sell
1,297
-118
-8% -$3.24K ﹤0.01% 3162
2023
Q3
$38.6K Buy
1,415
+754
+114% +$21.8K ﹤0.01% 2496
2023
Q2
$14.7K Sell
661
-518,895
-100% -$11.9M ﹤0.01% 3337
2023
Q1
$11.3M Buy
519,556
+61,087
+13% +$1.34M 0.05% 364
2022
Q4
$9.31M Buy
458,469
+148,864
+48% +$3.73M 0.05% 357
2022
Q3
$7.94M Sell
309,605
-53,698
-15% -$1.44M 0.06% 291
2022
Q2
$8.64M Buy
363,303
+102,693
+39% +$2.24M 0.06% 263
2022
Q1
$5.87M Buy
260,610
+11,350
+5% +$241K 0.05% 394
2021
Q4
$4.93M Buy
+249,260
New +$5.06M 0.05% 445
2020
Q4
Sell
-18,327
Closed -$319K 1510
2020
Q3
$319K Buy
18,327
+2,202
+14% +$35.1K 0.01% 1113
2020
Q2
$271K Buy
16,125
+1,058
+7% +$14.9K 0.01% 790
2020
Q1
$190K Sell
15,067
-14,709
-49% -$182K ﹤0.01% 429
2019
Q4
$360K Sell
29,776
-5,493
-16% -$76.5K 0.02% 857
2019
Q3
$499K Sell
35,269
-3,368
-9% -$41.4K 0.01% 987
2019
Q2
$431K Sell
38,637
-986
-2% -$11K 0.01% 996
2019
Q1
$465K Buy
39,623
+15,238
+62% +$189K 0.01% 589
2018
Q4
$326K Buy
24,385
+10,666
+78% +$141K 0.01% 177
2018
Q3
$192K Buy
+13,719
New +$192K 0.01% 1035

Other funds holding CORT